VitaFiber IMO
Commercial- Indications
- Dietary fiber supplement, Sugar substitute
Company intelligence / Profile preview
BioNeutra
Edmonton, Alberta, Canadabioneutra.ca ↗
- Ownership
- Private
- Employees
- ~26
- Development stage
- Commercial
01
Overview
BioNeutra has commercialized its lead product VitaFiber® IMO—a plant-based prebiotic soluble fiber and low-calorie sweetener—approved by the US FDA, European Food Safety Authority, and Health Canada. The company is expanding its portfolio to include resistant dextrin and other unique blends for gut health. It has received funding from major Canadian research organizations to develop new gut health products.
- Therapeutic areas
- GastroenterologyEndocrinologyOther
- Modalities
- Prebiotic fiber ingredientSoluble dietary fiberNutritive sweetener
- Industry
- Food & Nutrition
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with National Research Council Canada’s IRAP programNSERCAlberta Innovates
Beyond the preview
Go deeper on BioNeutra.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioNeutra.